Login / Signup

Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Douglas J HarrisonYueh-Yun ChiJing TianPooja HingoraniLeo MascarenhasGeoffrey B McCowageBrenda J WeigelRajkumar VenkatramaniSuzanne L WoldenTorunn I YockDavid A RodebergAndrea A Hayes-JordanLisa A TeotSheri L SpuntWilliam H MeyerDouglas S HawkinsBarry L ShulkinMarguerite T Parisi
Published in: Cancer medicine (2020)
Based on these data, FDG-PET does not appear to predict EFS in IR or HR-RMS. It remains to be determined whether FDG-PET has a role in predicting survival outcomes in other RMS subpopulations.
Keyphrases
  • positron emission tomography
  • computed tomography
  • pet ct
  • pet imaging
  • magnetic resonance imaging
  • young adults
  • palliative care
  • electronic health record
  • big data
  • magnetic resonance
  • machine learning
  • deep learning